An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease (Q44239114)
Jump to navigation
Jump to search
scientific article published in December 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease |
scientific article published in December 2002 |
Statements
1 reference
An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease (English)
1 reference
1 reference
Gregory M Chronowski
1 reference
Richard B Wilder
1 reference
Susan L Tucker
1 reference
Chul S Ha
1 reference
Andreas H Sarris
1 reference
Fredrick B Hagemeister
1 reference
Ibrahim Barista
1 reference
Mark A Hess
1 reference
James D Cox
1 reference
1 December 2002
1 reference
Identifiers
1 reference